Relia

ReLIA Diagnostic Systems, Inc. has developed a low-cost, high-performance, portable immunoassay system for Point-of-Care (POC) that provides the sensitivity, precision, accuracy and reliability of expensive and complex central laboratory system, with the advantage of onsite testing by non-technical personnel (CLIA-waivable). ReLIA is designed specifically to meet the needs and requirements of the POCT environment that requires rapid, quantitative testing of whole blood samples or other body fluids, without prior processing. The timely results, superior data management, connectivity, improved convenience, and cost effectiveness characterize the ReLIA system.

The ReLIA system is capable The ReLIA system represents a technological breakthrough in POCT that could revolutionize the POCT market. It is the first system capable of generating central lab quality, quantitative testing for chronic and infectious diseases within minutes, as well as high quality data management. The ReLIA system satisfies the increasing regulatory and customer requirements for quality control, result verification and system validation.

The ReLIA system is capable of testing up to 10 disease markers simultaneously. It can detect multiple biomarkers, including protein, virus, bacteria, and small molecules. The system satisfies the increasing regulatory and customer requirements for quality control, result verification and system validation. It automatically carries out numerous different internal control calibrations. No standard curves or other control measurements are required to be carried out by users. Assay specific information is stored in the instrument and accessed via a bar-code on each cassette. The instrument detects the addition of samples, times the assays, controls incubation temperature and then automatically reads the cassettes. The system is very robust, and capable of being remotely monitored and/or controlled by the ReLIA Call Center. Consequently, the system does not require on-site services. Internet connectivity is standard, and wireless connection is optional. The original validated data can be transmitted to any desired location for further analysis, or integration into large data sets for disease management or control. In addition, ReLIA system can be coupled with iMetrikus networks for healthcare IT management in a corporate, geographical, countrywide or worldwide basis.

ReLIA's headquarters are located in San Francisco, California. The company has a technology development center in Burlingame, California, and a product development and manufacturing center in Shenzhen, China. The manufacturing center has received both GMP certification and ISO13485.